Haiying Sun

机构：China Pharmaceutical University, Xuzhou Medical College, Thoracic Surgery Foundation, First Hospital of China Medical University, Tongji Hospital, Huazhong University of Science and Technology, China Medical University · ORCID：0000-0001-5380-5329

发表论文 263 篇 · 总被引 8113 次 · h-index 47

代表论文

• Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial (2025 · The Lancet Haematology · 被引 22)
• Inducible CCR2+ nonclassical monocytes mediate the regression of cancer metastasis (2024 · Journal of Clinical Investigation · 被引 20)
• Development of novel imipridone derivatives with potent anti-cancer activities as human caseinolytic peptidase P (hClpP) activators (2024 · Bioorganic Chemistry · 被引 9)
• Discovery of Dehydrogenated Imipridone Derivatives as Activators of Human Caseinolytic Protease P (2024 · Journal of Medicinal Chemistry · 被引 9)
• Single-cell dissection of chronic lung allograft dysfunction reveals convergent and distinct fibrotic mechanisms (2025 · JCI Insight · 被引 7)
• Inhibition of the cGAS‑STING Pathway Reduces Cisplatin-Induced Inner Ear Hair Cell Damage (2024 · Neuroscience Bulletin · 被引 7)